ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,059Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 421

$604K Total Retail Price of All Prescriptions

Rank: 20 out of 421

762 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 762 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 8,160 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 415 334 1 6
AMLODIPINE BESYLATE 400 344 2 4
LISINOPRIL 352 280 3 2
LEVOTHYROXINE SODIUM 326 257 4 30
OMEPRAZOLE 270 223 5 28
FUROSEMIDE 250 235 6 5
METFORMIN HCL 210 162 7 43
METOPROLOL TARTRATE 189 132 8 3
HYDROCHLOROTHIAZIDE 187 158 9 18
POTASSIUM CHLORIDE 186 163 10 19
NAMENDA 177 177 11 125
ATENOLOL 141 127 12 17
PRAVASTATIN SODIUM 139 129 13 12
CITALOPRAM HBR 133 94 14 73
DONEPEZIL HCL 133 132 14 92
CARVEDILOL 133 118 14 1
GABAPENTIN 119 76 17 58
QUETIAPINE FUMARATE 118 114 18 166
ALENDRONATE SODIUM 113 113 19 107
TAMSULOSIN HCL 105 105 20 83
EXELON 104 99 21 148
MIRTAZAPINE 104 102 21 147
HYDROCODONE-ACETAMINOPHEN 102 84 S3 23 50
RISPERIDONE 99 68 24 173
CLONIDINE HCL 97 66 25 33
TRAMADOL HCL 96 80 26 63
TRAZODONE HCL 88 69 27 126
DIVALPROEX SODIUM 87 45 28 175
DIGOXIN 82 78 29 14
SERTRALINE HCL 78 74 30 76
ESCITALOPRAM OXALATE 76 62 31 110
ATORVASTATIN CALCIUM 74 65 32 9
ZOLPIDEM TARTRATE 73 37 33 46
METOPROLOL SUCCINATE 71 51 34 8
LOSARTAN POTASSIUM 69 63 35 16
WARFARIN SODIUM 67 66 36 7
GLIPIZIDE 67 42 36 112
DIVALPROEX SODIUM ER 65 29 38 197
CLOPIDOGREL 65 59 38 10
MEGESTROL ACETATE 64 62 R 40 145
SEROQUEL 62 48 41 200
CYMBALTA 61 42 42 160
NEXIUM 60 30 43 54
NIFEDIPINE ER 59 54 44 53
ADVAIR DISKUS 59 32 44 117
BENZTROPINE MESYLATE 58 14 R 46 205
GLYBURIDE 58 39 R 46 143
PLAVIX 57 52 48 13
CARBIDOPA-LEVODOPA 57 57 48 208
DIOVAN 55 54 50 23
COMBIVENT 54 27 51 120
LOVASTATIN 54 51 51 49
RANITIDINE HCL 54 48 51 51
LANTUS 54 54 51 118
HYDRALAZINE HCL 53 50 55 21
ALLOPURINOL 53 43 55 56
CRESTOR 52 30 57 15
ISOSORBIDE MONONITRATE ER 51 51 58 11
LOSARTAN-HYDROCHLOROTHIAZIDE 50 40 59 36
PANTOPRAZOLE SODIUM 50 49 59 41
JANUVIA 50 42 59 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.